histamine H3 antagonists (Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namehistamine H3 antagonists (Pfizer)
Drug Alias Namehistamine H3 antagonists (Wyeth)PF-03900422WAY-364416PF-3900422WAY-361754 +[6] 
ClassificationSmall molecules
Mechanisms of ActionHistamine H3 receptor antagonists
TargetsHistamine H3 receptor
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth LlcPfizer Inc
Active IndicationsN/A
Inactive IndicationsCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A